Comments
Loading...

Y-mAbs Therapeutics

YMABNASDAQ
Logo brought to you by Benzinga Data
$10.54
0.242.33%
At close: -
$10.54
0.000.00%
After Hours: 4:37 PM EDT

Y-mAbs Therapeutics (NASDAQ:YMAB) Stock, Earnings Estimates, EPS, And Revenue

Y-mAbs Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 27
EPS Estimate
$-0.110
Quarterly Revenue Estimate
$25.5M
Annual Revenue
(as of Sep 30)
$84.6M

Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Y-mAbs Therapeutics (YMAB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-08$-0.16$-0.160.00 %
Jun 20242024-08-12$-0.21$-0.13-61.5 %
Mar 20242024-05-07$-0.15$-0.14-7.14 %
Dec 20232024-02-29$-0.02$-0.2090.0 %

Y-mAbs Therapeutics (YMAB) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-11-08$18.46M$23.26M-20.6 %
Jun 20242024-08-12$22.80M$23.02M-0.96 %
Mar 20242024-05-07$19.93M$22.22M-10.3 %
Dec 20232024-02-29$23.36M$20.95M11.5 %

FAQ

Q

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

A

Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Y-mAbs Therapeutics (NASDAQ:YMAB)?

A

The Actual EPS was $-0.16, which hit the estimate of $-0.16.

Q

What were Y-mAbs Therapeutics’s (NASDAQ:YMAB) revenues?

A

The Actual Revenue was $18.5M, which missed the estimate of $23.3M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch